| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | 0.46 | 0.01 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.01 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | 0.097 | 0.01 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.19 | 0.01 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |